[Federal Register Volume 67, Number 123 (Wednesday, June 26, 2002)]
[Notices]
[Page 43135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-16075]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Clinical Trials Network.
    Date: July 9, 2002.
    Time: 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: William C. Grace, PhD, Deputy Director, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Training and Career Development.
    Date: July 26, 2002.
    Time: 10:30 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Mark Sweiter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

(Catalog of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse 
Scientist Development Award for Clinicians, Scientist Development 
Awards, and Research Scientist Award; 93.278, Drug Abuse National 
Research Service Awards for Research Training; 93.279, Drug Abuse 
Research Programs, National Institutes of Health, HHS)


    Dated: June 18, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-16075 Filed 6-25-02; 8:45 am]
BILLING CODE 4140-01-M